St. John's Wort Extract LI 160 for the Treatment of Atypical Depression

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2002
The aim of tis study is to assess the efficacy and safety of Jarsin® 300 mg as an acute treatment in mild to moderate depression with atypical features.
Epistemonikos ID: b75892e0fedb011176fe47d665d4b2e69cf35d7c
First added on: May 05, 2024